The apex court took note of an office memorandum (OM), dated May 22, 2013 by Health Ministry. The OM clarified in consultation with the National AIDS control Organization that stem cell banking is a part of ‘health care services’ and qualifies for exemption. “It is evident that the appellant’s services fall within the ambit of “Healthcare Services” as defined under the exemption notification. These services are preventive and curative in nature and encompass diagnosis, treatment, and care,” a division bench of Justices J B Pardiwala and R Mahadevan said while disposing of a petition filed by Stemcyte India against order of Customs, Excise and Service Tax Appellate Tribunal (CESTAT).

CESTAT in its order dated August 2, 2024, rejected the appeals filed by the company and upheld the orders passed by the lower authorities. It held that the services of enrolment, collection, processing, and storage of umbilical cord blood stem cells, provided by the appellant during the period from July 1, 2012 and February 16, 2014 do not fall within the scope of “Healthcare Services”. Consequently, the company was held liable to pay service tax on the said services along with interest and penalties.